[關(guān)鍵詞]
[摘要]
目的 觀察小檗胺的體外抗病毒作用,并基于Ⅰ型干擾素(IFN-Ⅰ)通路的抗病毒天然免疫反應(yīng)探討其作用機制。方法 CCK-8法檢測0.001、0.010、0.100、1.000、10.000、100.000 μmol·L-1的小檗胺對A549細胞活力的影響;表達綠色熒光蛋白的水皰性口炎病毒(VSV-GFP)以0.05的感染復(fù)數(shù)(MOI)感染A549細胞制備模型,流式細胞術(shù)檢測共同孵育12 h的小檗胺2.5、5.0、10.0 μmol·L-1對GFP陽性細胞比例的影響;VSV感染A549細胞,Western blotting檢測小檗胺對VSV病毒G蛋白表達的影響;小檗胺使用預(yù)處理12 h、病毒吸附過程中給藥2 h、病毒吸附后給藥10 h 3種不同方式給藥,通過流式細胞術(shù)檢測其對VSV-GFP在A549細胞中復(fù)制的影響;分別使用甲型流感病毒(H1N1)(MOI=0.05),腦心肌炎病毒(EMCV)(MOI=3)和單純皰疹病毒1型(HSV-1)(MOI=1)感染A549細胞,同時給藥共同孵育12 h后,實時熒光定量PCR(qRT-PCR)檢測小檗胺對病毒RNA表達的影響;小檗胺10.0 μmol·L-1處理A549細胞24 h,進行轉(zhuǎn)錄組測序分析;10 μmol·L-1小檗胺處理MEF細胞12 h后,qRT-PCR法檢測Ifnb1、Ifit1、Ifit2、Ifi44基因的mRNA表達;利用IFN刺激性DNA (ISD)轉(zhuǎn)染THP-1細胞,預(yù)先激活I(lǐng)FN-I信號通路,4~6 h加入小檗胺5、10 μmol·L-1處理12 h,qRT-PCR法檢測IFNB1、IFIT1、IFIT2、IFI44基因的mRNA表達。結(jié)果 濃度為10 μmol·L-1及以下時,小檗胺對A549細胞均未顯示出明顯的細胞毒性;與模型組相比,小檗胺劑量相關(guān)性地減少了VSV-GFP陽性細胞的比例(P<0.05、0.001),明顯減少了病毒的VSV-G蛋白表達;小檗胺對VSV的吸附過程沒有影響,而預(yù)處理或吸附后給藥可以顯著抑制病毒復(fù)制;與模型組比較,小檗胺劑量相關(guān)性地抑制了H1N1、EMCV和HSV-1的病毒基因表達(P<0.001);轉(zhuǎn)錄組測序和qRT-PCR結(jié)果表明,小檗胺促進細胞基于IFN-I信號通路的抗病毒免疫激活;在ISD刺激后,小檗胺誘導(dǎo)更高水平的IFNB1、IFIT1、IFIT2、IFI44 mRNA表達(P<0.05、0.01、0.001)。結(jié)論 小檗胺可能通過促進基于IFN-I通路的抗病毒天然免疫反應(yīng)抑制多種病毒復(fù)制。
[Key word]
[Abstract]
Objective Observe the antiviral effect of berbamine in vitro and explore its mechanism of action based on the antiviral natural immune response of the type I interferon (IFN-I) pathway. Methods CCK-8 method for detecting effect of 0.001, 0.010, 0.100, 1.000, 10.000, 100.000 μmol·L-1 berbamine on the viability of A549 cells. The vesicular stomatitis virus expressing green fluorescent protein (VSV-GFP) infected A549 cells with 0.05 multiplicity of infection (MOI). Flow cytometry was used to detect the effect of berbamine 2.5, 5.0, 10.0 μmol·L-1 co-incubated for 12 h on the proportion of GFP positive cells. VSV infected A549 cells, and the effect of berbamine on the expression of VSV-G protein was detected by Western blotting. Berberine was administered in three different ways: pre-treatment for 12 h, administration during virus adsorption for 2 h, and administration after virus adsorption for 10 h, and its effect on VSV-GFP replication in A549 cells was detected by flow cytometry. A549 cells were infected with influenza A virus (H1N1) (MOI = 0.05), myocarditis virus (EMCV) (MOI = 3), and herpes simplex virus type 1 (HSV-1) (MOI = 1), respectively. After co-incubation for 12 h, the effect of berberine on virus RNA expression was detected by real-time fluorescence quantitative PCR (qRT-PCR). A549 cells were treated with berbamine 10.0 μmol·L-1 for 24 h, and transcriptome sequencing was performed. After treating MEF cells with 10 μmol·L-1 berbamine for 12 h, qRT-PCR was used to detect the mRNA expression of Ifnb1, Ifit1, Ifit2, and Ifi44 genes. Transfection of THP-1 cells using IFN stimulated DNA (ISD) was performed, and the IFN-I signaling pathway was pre-activated. Berberine 5 and 10 μmol·L-1 were added after 4—6 h to treat for 12 h. mRNA expression of IFNB1, IFIT1, IFIT2, and IFI44 genes was detected by qRT-PCR. Results At concentrations of 10 μmol·L-1 and below, berbamine did not exhibit significant cytotoxicity on A549 cells. Compared with the model group, berbamine dose dependently reduced the proportion of VSV-GFP positive cells (P < 0.05, 0.001), and significantly reduced the expression of virus VSV-G protein. Berberine had no effect on the adsorption process of VSV, while pre-treatment or administration after adsorption can significantly inhibit virus replication. Compared with model group, berberine dose-related inhibition of viral gene expression in H1N1, EMCV, and HSV-1 (P < 0.001). The Results of transcriptome sequencing and qRT-PCR showed that berbamine promoted the antiviral immune activation of cells based on IFN-I signaling pathway. After ISD stimulation, berbamine induced higher levels of IFNB1, IFIT1, IFIT2, and IFI44 mRNA expression (P < 0.05, 0.01, 0.001). Conclusions Berbamine may inhibit the replication of multiple virus by promoting antiviral innate immune responses based on the IFN-I signaling.
[中圖分類號]
R965
[基金項目]
中國科協(xié)青年人才托舉工程項目(2020-QNRC1-03);國家自然科學(xué)基金資助項目(82001663)